GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,629.00
Bid: 1,629.00
Ask: 1,629.50
Change: -11.00 (-0.67%)
Spread: 0.50 (0.031%)
Open: 1,633.00
High: 1,641.00
Low: 1,611.00
Prev. Close: 1,640.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Markets pull back from five-month high as banks fall

Wed, 23rd Oct 2013 11:15

Concerns over the Chinese economy and a weak performance by banking stocks halted a nine-day winning streak for UK markets on Wednesday, as investors chose to take profits following a strong run.The FTSE 100 snapped a nine-day winning streak this morning, pulling back from Tuesday's finish of 6,695.66, the index's highest closing high since May 28th when it closed at 6,762.01.Stocks have surged over the past week as investors celebrated the end to the US government shutdown and the short-term deal to raise the debt ceiling. Meanwhile, hopes over a continuation of Federal Reserve monetary stimulus were sparked yesterday after a disappointing September jobs report.Weighing on markets this morning was a sharp sell-off across Asian indices overnight on the back of concerns over the Chinese banking sector following a report that said that debt write-offs at the country's biggest lenders tripled in the first half. Investors were also focusing on the People's Bank of China's decision on Wednesday to refrain from adding liquidity to the market through new reverse repurchase operations, which led to a sharp increase in the country's benchmark money market rate. In other news, the minutes of the latest Bank of England meeting were released this morning and showed that the Monetary Policy Committee was unanimous in its decision to keep policy unchanged as recent economic data pointed to a "robust recovery in activity".Banks, ex-div stocks provide a dragBanks all over Europe were out of favour after the European Central Bank said it would start to review the balance sheets of 130 institutions across the continent. RBS, Barclays, Lloyds, HSBC and Standard Chartered were all registering losses in London.A number of stocks were also trading in the red after going ex-dividend, including Smiths Group, BAE System, Rolls-Royce, John Menzies, Senior, William Hill, Rank Group, Barratt Developments and JD Wetherspoon.Banknote printer and ID services firm De La Rue was a big mover with shares sinking after the company warned that it would miss its full-year profit target by £10m owing to "challenging trading conditions".Drugs group GlaxoSmithKline was also weighing on the market ahead of the release of its third-quarter results due out later on amid concerns over the impact of a corruption probe in China on sales.Chip designer ARM Holdings fell for the second straight day as investors gave a cool reaction to its third-quarter results. JPMorgan Cazenove said this morning that it sees "no reason to be building positions at this time and would take profits in the short term."Sports Direct edged higher after saying that sales in the nine weeks to September 29th were up 15.1% despite some tough comparatives with last year. Fellow retailer Home Retail also rose after a 53% jump in first-half profits owing to sales growth at its Argos and Homebase chains.Costa and Premier Inn owner Whitbread was lower after Deutsche Bank downgraded the stock to 'hold', saying that it's time to "consolidate and take stock" after a great year.Meanwhile, telecoms firm Vodafone was in demand as speculation continues to ramp up about a possible bid from US counterpart AT&T. Credit Suisse has raised its target for the UK-listed stock, saying it sees a 50% chance of a bid.FTSE 100 - RisersRSA Insurance Group (RSA) 127.00p +2.50%Persimmon (PSN) 1,244.00p +1.39%International Consolidated Airlines Group SA (CDI) (IAG) 363.80p +1.34%Travis Perkins (TPK) 1,804.00p +1.23%United Utilities Group (UU.) 713.50p +1.21%Resolution Ltd. (RSL) 351.40p +1.15%Legal & General Group (LGEN) 212.40p +1.14%Capita (CPI) 985.50p +1.13%Shire Plc (SHP) 2,521.00p +1.12%Weir Group (WEIR) 2,361.00p +1.11%FTSE 100 - FallersSmiths Group (SMIN) 1,394.00p -4.19%Anglo American (AAL) 1,510.00p -2.96%Antofagasta (ANTO) 878.00p -2.88%Royal Bank of Scotland Group (RBS) 353.20p -2.43%Rio Tinto (RIO) 3,187.00p -2.28%CRH (CRH) 1,513.00p -2.07%ARM Holdings (ARM) 983.50p -2.04%BHP Billiton (BLT) 1,914.50p -1.85%Barclays (BARC) 267.70p -1.80%GlaxoSmithKline (GSK) 1,575.00p -1.62%FTSE 250 - RisersLaird (LRD) 239.90p +6.29%Pace (PIC) 303.80p +4.76%Home Retail Group (HOME) 191.60p +3.96%African Barrick Gold (ABG) 172.60p +3.35%Kenmare Resources (KMR) 22.48p +3.26%IP Group (IPO) 145.90p +3.04%Alent (ALNT) 363.00p +2.25%Chemring Group (CHG) 219.80p +2.19%Telecom Plus (TEP) 1,514.00p +2.16%BH Global Ltd. USD Shares (BHGU) 11.63 +2.02%FTSE 250 - FallersDe La Rue (DLAR) 889.50p -9.33%International Personal Finance (IPF) 622.00p -6.96%Premier Oil (PMO) 323.10p -4.97%Telecity Group (TCY) 786.00p -4.96%Centamin (DI) (CEY) 49.65p -4.24%Evraz (EVR) 129.50p -3.50%Kazakhmys (KAZ) 253.40p -3.28%AZ Electronic Materials SA (DI) (AZEM) 288.80p -2.43%Soco International (SIA) 405.20p -1.89%Hansteen Holdings (HSTN) 106.00p -1.85%BC
More News
22 Aug 2023 13:09

UK's Wood Group raises profit forecast on contract wins; shares rise

CFO David Kemp to retire

*

Read more
21 Aug 2023 22:37

US FDA approves Pfizer's maternal RSV vaccine to protect infants

Aug 21 (Reuters) - The U.S. Food and Drug Administration on Monday approved Pfizer's respiratory syncytial virus (RSV) vaccine for use in women during the middle of the third trimester of pregnancy to protect their babies.

Read more
17 Aug 2023 19:53

Charity says HIV drug deal with GSK's ViiV on ice over price secrecy

(Alliance News) - The Doctors Without Borders, or MSF, charity said Thursday a deal aimed to bring long-term preventative HIV treatment to vulnerable populations was on hold after the drugmaker imposed pricing confidentiality.

Read more
17 Aug 2023 11:56

LONDON MARKET MIDDAY: Stocks down over US rate hike worries

(Alliance News) - Stock prices in Europe were lower at midday on Thursday, after the US Federal Reserve warned that a further interest rate hike may be on the cards.

Read more
17 Aug 2023 08:53

LONDON MARKET OPEN: Stocks fall further after hawkish US Fed minutes

(Alliance News) - Stock prices in London opened in the red on Thursday, amid renewed concerns about further US interest rate increases.

Read more
13 Aug 2023 14:06

Sunday newspaper round-up: White Hydrogen, Bank of England, AI

(Sharecast News) - America's Geological survey estimates that if even a small fraction of naturally occurring - and clean or so-called 'white' - hydrogen beneath the earth's surface were recovered, that would last for hundreds of years. Among the backers of the hydrogen industry is Bill Gates, who ploughed $90m into Koloma, a company hunting for natural hydrogen along the US's Midcontinental Rift System. White hydrogen has also been discovered in Europe, in France's Lorraine region. Nonetheless, the true potential of the stuff will hinge on the findings from those early projects, says Philip Ball, research fellow at Keele University. - Guardian

Read more
10 Aug 2023 15:46

UK dividends calendar - next 7 days

Friday 11 August 
Blackrock Latin American Investment Trust PLCdividend payment date
Caffyns PLCdividend payment date
CMC Markets PLCdividend payment date
Montanaro UK Smaller Cos Investment Trust PLCdividend payment date
Next 15 Group PLCdividend payment date
Ninety One PLC and Ltddividend payment date
Schroder European Real Estate Investment Trust PLCdividend payment date
Sportech PLCspecial dividend payment date
Telecom Plus PLCdividend payment date
Triad Group PLCdividend payment date
Wincanton PLCdividend payment date
Monday 14 August 
Mountview Estates PLCdividend payment date
Tuesday 15 August 
Tatton Asset Management PLCdividend payment date
Wednesday 16 August 
Murray International Trust PLCdividend payment date
Shoe Zone PLCdividend payment date
Thursday 17 August 
4imprint Group PLCex-dividend payment date
abrdn PLCex-dividend payment date
abrdn Property Income Trust Ltdex-dividend payment date
Anglo American PLCex-dividend payment date
Baillie Gifford UK Growth Trust PLCex-dividend payment date
Berkeley Group Holdings PLCex-dividend payment date
BlackRock Sustainable American Income Trust PLCex-dividend payment date
Bridgepoint Group PLCex-dividend payment date
Chemring Group PLCex-dividend payment date
ConvaTec Group PLCex-dividend payment date
Ecofin US Renewables Infrastructure Trust PLCex-dividend payment date
GSK PLCex-dividend payment date
Henderson Opportunities Trust PLCex-dividend payment date
Hiscox Ltdex-dividend payment date
Impact Healthcare REIT PLCex-dividend payment date
Imperial Brands PLCex-dividend payment date
Investec PLC and Ltdex-dividend payment date
iomart Group PLCex-dividend payment date
Keller Group PLCex-dividend payment date
Lancashire Holdings Ltdex-dividend payment date
London Stock Exchange Group PLCex-dividend payment date
Montanaro European Smaller Cos Trust PLCex-dividend payment date
Murray Income Trust PLCex-dividend payment date
NextEnergy Solar Fund Ltdex-dividend payment date
Octopus Renewables Infrastructure Trust PLCex-dividend payment date
Pershing Square Holdings Ltdex-dividend payment date
Rotork PLCex-dividend payment date
Sabre Insurance Group PLCex-dividend payment date
Schroders PLCex-dividend payment date
Sirius Real Estate Ltddividend payment date
Tritax EuroBox PLCex-dividend payment date
UK Commercial Property REIT Ltdex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
7 Aug 2023 08:12

PRESS: Inflexion among firms looking to buy Haleon's nicotine business

(Alliance News) - Sky News reported on Sunday that Inflexion Private Equity Partners is among suitors for Haleon PLC's Nicotinell anti-smoking aid.

Read more
3 Aug 2023 16:31

GSK Nigeria calls an end to its business, to return cash

ABUJA, Aug 3 (Reuters) - GlaxoSmithKline (GSK) Nigeria said on Thursday it plans to stop doing business after evaluating the options for moving to a third-party distribution model for its drugs and consumer healthcare goods.

Read more
2 Aug 2023 20:45

TOP NEWS: GSK sues Pfizer over patent infingements for RSV vaccine

(Alliance News) - GSK PLC on Wednesday sued Pfizer Inc over patent infringement, alleging Pfizer's respiratory syncytial virus vaccine steals key elements of GSK's version.

Read more
2 Aug 2023 15:14

GSK sues Pfizer in US for patent infringement over RSV vaccine

Aug 2 (Reuters) - British biopharmaceutical giant GSK sued Pfizer in a U.S. court on Wednesday, alleging that Pfizer's respiratory syncytial virus (RSV) vaccine Abrysvo violates GSK's patent rights in its rival RSV shot Arexvy.

Read more
2 Aug 2023 14:28

GSK sues Pfizer in US for patent infringement over RSV vaccine

Aug 2 (Reuters) - British biopharmaceutical giant GSK sued Pfizer in Delaware federal court on Wednesday, accusing Pfizer's respiratory syncytial virus (RSV) vaccine Abrysvo of violating GSK's patent rights in its rival RSV shot Arexvy.

Read more
2 Aug 2023 10:41

Sensodyne maker Haleon's shiny forecast signals price hikes unlikely to dent demand

Shares down 1% on slight decline in H1 adj operating margin

*

Read more
2 Aug 2023 08:23

TOP NEWS: Haleon boosts annual guidance after solid first half

(Alliance News) - Haleon PLC on Wednesday upped its annual organic revenue growth guidance following a solid revenue performance in the first half of 2023.

Read more
31 Jul 2023 19:42

IN BRIEF: GSK hails US FDA approval for cancer treatment, Jemperli

GSK PLC - London-based pharmaceutical company - Jemperli plus chemotherapy approved in the US by the Food & Drug Administration as the first new frontline treatment option in decades for primary advanced or recurrent endometrial cancer. Notes Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy. Hesham Abdullah, senior vice president and global head of oncology development at GSK, says: "Today's approval underscore our belief in the potential for Jemperli to transform cancer treatment as a backbone immuno-oncology therapy."

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.